News Related to Clozapine

Related coverage linked through entity extraction aliases.

Speech Latency Biomarker Improves Schizophrenia Trial Outcomes; Clozapine Shows Efficacy

Mar 12, 2026

Researchers identify speech latency as a biomarker to enrich schizophrenia clinical trials, while a separate study finds clozapine more effective than alternatives for patients who fail initial antipsychotic treatment.

Newron Secures Up to €38 Million for Phase III Evenamide Program in Schizophrenia

Feb 17, 2026

Newron Pharmaceuticals has secured up to €38 million in milestone-based financing from European and Asian investors to advance its Phase III ENIGMA-TRS program evaluating evenamide as an add-on therapy for treatment-resistant schizophrenia.